These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 25237840)
1. Evaluation of comparative performance of orally inhaled drug products in view of the classical bioequivalence paradigms: an analysis of the current scientific and regulatory dilemmas of inhaler evaluation. Horhota ST J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):408-13. PubMed ID: 25237840 [TBL] [Abstract][Full Text] [Related]
2. Orally inhaled drug performance testing for product development, registration, and quality control. Lastow O; Svensson M J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):401-7. PubMed ID: 25237712 [TBL] [Abstract][Full Text] [Related]
3. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences. Lu D; Lee SL; Lionberger RA; Choi S; Adams W; Caramenico HN; Chowdhury BA; Conner DP; Katial R; Limb S; Peters JR; Yu L; Seymour S; Li BV AAPS J; 2015 May; 17(3):546-57. PubMed ID: 25758352 [TBL] [Abstract][Full Text] [Related]
4. Considerations for Designing In Vitro Bioequivalence (IVBE) Studies for Pressurized Metered Dose Inhalers (pMDIs) with Spacer or Valved Holding Chamber (S/VHC) Add-on Devices. Sandell D; Mitchell JP J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):156-81. PubMed ID: 25089555 [TBL] [Abstract][Full Text] [Related]
5. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products. Tsong Y; Dong X; Shen M; Lostritto RT J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132 [TBL] [Abstract][Full Text] [Related]
6. A European perspective on orally inhaled products: in vitro requirements for a biowaiver. García-Arieta A J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):419-29. PubMed ID: 25238116 [TBL] [Abstract][Full Text] [Related]
7. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols. Part 3. Final report on a statistical procedure for determining equivalence. Christopher D; Adams W; Amann A; Bertha C; Byron PR; Doub W; Dunbar C; Hauck W; Lyapustina S; Mitchell J; Morgan B; Nichols S; Pan Z; Singh GJ; Tougas T; Tsong Y; Wolff R; Wyka B AAPS PharmSciTech; 2007 Nov; 8(4):E90. PubMed ID: 18181550 [TBL] [Abstract][Full Text] [Related]
8. In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches. Forbes B; Bäckman P; Christopher D; Dolovich M; Li BV; Morgan B AAPS J; 2015 Jul; 17(4):837-52. PubMed ID: 25940082 [TBL] [Abstract][Full Text] [Related]
9. Establishing bioequivalence for inhaled drugs; weighing the evidence. Daley-Yates PT; Parkins DA Expert Opin Drug Deliv; 2011 Oct; 8(10):1297-308. PubMed ID: 21699442 [TBL] [Abstract][Full Text] [Related]
10. A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled Pharmaceuticals. Tougas TP; Goodey AP; Hardwell G; Mitchell J; Lyapustina S AAPS PharmSciTech; 2017 Feb; 18(2):451-461. PubMed ID: 27068528 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review. Mitchell J; Newman S; Chan HK AAPS PharmSciTech; 2007 Dec; 8(4):E110. PubMed ID: 18181531 [TBL] [Abstract][Full Text] [Related]
12. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation. Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701 [TBL] [Abstract][Full Text] [Related]
13. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy. Verbeeck RK; Kanfer I; Walker RB Eur J Pharm Sci; 2006 May; 28(1-2):1-6. PubMed ID: 16413762 [TBL] [Abstract][Full Text] [Related]
14. An overview of regulations for bioequivalence assessment of locally acting orally inhaled drug products for the United States, Europe, Canada, and India. Patil PP; Pawar AP; Mahadik KR; Gaikwad VL Expert Opin Drug Deliv; 2021 Dec; 18(12):1843-1855. PubMed ID: 34814778 [TBL] [Abstract][Full Text] [Related]
15. Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report. Adams WP; Ahrens RC; Chen ML; Christopher D; Chowdhury BA; Conner DP; Dalby R; Fitzgerald K; Hendeles L; Hickey AJ; Hochhaus G; Laube BL; Lucas P; Lee SL; Lyapustina S; Li B; O'Connor D; Parikh N; Parkins DA; Peri P; Pitcairn GR; Riebe M; Roy P; Shah T; Singh GJ; Sharp SS; Suman JD; Weda M; Woodcock J; Yu L J Aerosol Med Pulm Drug Deliv; 2010 Feb; 23(1):1-29. PubMed ID: 20131983 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary drug delivery by powder aerosols. Yang MY; Chan JG; Chan HK J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765 [TBL] [Abstract][Full Text] [Related]